STOCK TITAN
  1. Home
  2. Sec-filings
  3. TSBX
  4. [SC 14D9/A] Turnstone Biologics Corp. Amended Tender Offer Recommendation

[SC 14D9/A] Turnstone Biologics Corp. Amended Tender Offer Recommendation

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SC 14D9/A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock TSBX logo
Turnstone Biologics Corp

NASDAQ:TSBX

TSBX Rankings

#9621 Ranked by Market Cap
N/A Ranked by Dividends

TSBX Latest News

May 8, 2025
Turnstone Biologics Corp. Reports First Quarter 2025 Financial Results and Provides Recent Corporate Highlights
Mar 28, 2025
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
Feb 4, 2025
Turnstone Biologics Announces Plans to Explore Strategic Alternatives
Nov 12, 2024
Turnstone Biologics Corp. Reports Third Quarter 2024 Financial Results and Provides Recent Business Highlights
Nov 5, 2024
Turnstone Biologics Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Solid Tumors at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting

TSBX Latest SEC Filings

Jul 17, 2025
[8-K/A] Turnstone Biologics Corp. Amends Material Event Report
Jul 11, 2025
[SC 14D9] Turnstone Biologics Corp. Tender Offer Recommendation
Jul 1, 2025
[8-K/A] Turnstone Biologics Corp. Amends Material Event Report
Jun 27, 2025
[8-K] Turnstone Biologics Corp. Reports Material Event
Jun 27, 2025
[SC14D9C] Turnstone Biologics Corp. SEC Filing

TSBX Stock Data

8.53M
18.26M
7.7%
58.73%
1.73%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
LA JOLLA